2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92562°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
'½Å¶û¼ö¾÷¡¯ ±èÁ¾¹Î '½Å¶û¼ö¾÷ ¹Þ°í ½Í¾ú´Ù¡± Ãâ»çÇ¥ ´øÁ® (2024-10-23)
¡®µµ½É°ø¾ç°£¡¯°ú ÇÔ²² ¸¸³ª´Â ºÎó´Ô °¡¸£Ä§ÀÇ Âü¸À (2024-09-05)
LG CNS, °ø¸ð°¡ ÃÖ»ó´Ü 6¸¸1900¿ø È®Á¤¡¦ 21ÀϺÎÅÍ Ã»¾à (2025-01-18)
LG India¡¯s K-pop Contest Inspires India¡¯s Youth to Pursue ... (2025-02-16)
¼­¿ï´ë °ø´ë, Çкλý ·Îº¿ ½Ç½À½Ç ¡®ÁÖÁ¾³² âÀǰøÇÐ ½ºÆ©µð¿À¡¯ (2024-12-30)
Avania Appoints Innovative Operations Strategist Charlene Da... (2024-12-11)
LIG³Ø½º¿ø, 2ÆÇ±³ÇϿ콺 °³¼Ò¡¦ ¹Ì·¡ ±â¼ú °³¹ß °ÅÁ¡ (2025-01-28)
´ë¿õÁ¦¾à, ½Å¾à ¼ÒÀç ¡®È­ÇÕ¹°¡¯ °ø°³ (2025-01-28)
Mary Kay Inc. Names Tara Eustace Chief Opportunity and Sales... (2025-03-17)
VeriSilicon¡¯s Ultra-Low Energy NPU Provides Over 40 TOPS fo... (2025-06-21)
ÀâÄÚ¸®¾Æ, µðÁöÅÐ ¸íÇÔ ¾Û '‡´' »õÇØ ÀÎ»ç ³ª´©±â À̺¥Æ® (2025-01-09)
°úÇбâ¼úÁ¤º¸Åë½ÅºÎ-IITP Áö¿ø ´ëÇС¤±â¾÷Çù·ÂÇü ¾ÆÄ«µ¥¹Ì (2024-09-07)
°Ç±¹´ë µ¿¹°º´¿ø, ¡®¹Ý·Áµ¿¹° ÀÀ±ÞÁßȯÀÚÀÇÇÐȸ¡¯ ·¹º§2 ÀÎÁõ ȹ... (2024-10-25)
»ï¼ºÀüÀÚ, »õ·Î¿öÁø °¶·°½Ã AI·Î °íµµÈ­µÈ °³ÀÎÈ­ °æÇè Á¦°ø (2024-12-31)
´ë¿õÁ¦¾à, ÃÖ±Ù 5³â ƯÇã Áß 88%°¡ ½Å¾à °ü·Ã (2024-10-06)
ÆÄ¿ì, ¡®¶óÀÌºê ½ºÅ×ÀÌÁö¡¯·Î ÆÒµé¿¡ ÀØÁö ¸øÇÒ ÇÏ·ç ¼±¹° (2025-02-17)
KB±¹¹ÎÀºÇà-±¹¹ÎÀÌÁÖ, ÇØ¿ÜÀÌÁÖ °í°´ ´ë»ó ¿Üȯ Á¾ÇÕ ¼­ºñ½º (2024-11-04)
Xsolla Expands Its Commitment to LATAM Game Development With... (2025-04-06)
LSÀÏ·ºÆ®¸¯, Åׯ®¶ó Å×Å©¿Í ±Û·Î¹ú Àü·Â ½ÃÀå °ø·« ¸Â¼Õ (2025-02-08)
¡®¾È·¦ TIP¡¯¿¡ ÅÚ·¹±×·¥ ¹× ·£¼¶¿þ¾î Ưȭ ¸ð´ÏÅ͸µ ±â´É Ãß°¡ (2024-11-15)
PUMA to Open First-Ever European Flagship Store on Oxford St... (2025-04-16)
Former Mitsubishi IP Leader to Head Sisvel Japan (2025-04-16)
LG Strengthens EdTech Leadership With Expanded LG CreateBoar... (2025-07-01)
One, Two, Three-Peat: Mary Kay Inc. Ranks No. 1 Global Direc... (2025-07-01)
¿ÍÄÞÄÚ¸®¾Æ-Çѱ¹¸¸È­¿µ»óÁøÈï¿ø, À¥Å÷ ÀÎÀç À°¼º Çù¾à (2024-10-18)
       [ÀÌÀü][1]....[382][383][384][385][386][387][388][389][390]...[3703][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..